Table 3 Median predicted proportion of the Turkish cattle population with an FMD Log10(Sp titre) of <2 and zero (below 1:32 dilution detection threshold), stratified by age [95% PI in brackets].
Serotype | Log10 SP titre | Age [months] | October | February | |
|---|---|---|---|---|---|
One-dose primary | One-dose primary | Two-dose primary | |||
O | <2 | <6 | 72% [69–73] | 100% [100–100] | 100% [100–100] |
6 -<18 | 45% [42–48] | 76% [71–80] | 51% [47–56] | ||
18 -<24 | 38% [33–44] | 63% [55–71] | 57% [48–67] | ||
≥24 | 34% [28–42] | 59% [48–69] | 58% [48–69] | ||
Total | 42% [38–47] | 68% [60–75] | 60% [53–68] | ||
0 | <6 | 62% [60–63] | 100% [100–100] | 100% [100–100] | |
6 -<18 | 28% [26–31] | 58% [52–65] | 38% [33–43] | ||
18 -<24 | 22% [18–27] | 44% [35–54] | 38% [27–51] | ||
≥24 | 19% [13–26] | 39% [27–52] | 38% [26–52] | ||
Total | 27% [23–31] | 51% [43–59] | 44% [35–54] | ||
A | <2 | <6 | 84% [83–86] | 100% [100–100] | 100% [100–100] |
6 -<18 | 64% [60–68] | 81% [76–85] | 63% [58–68] | ||
18 -<24 | 55% [48–63] | 70% [60–78] | 64% [53–74] | ||
≥24 | 51% [41–61] | 65% [52–76] | 64% [52–75] | ||
Total | 59% [52–67] | 73% [65–80] | 68% [58–68] | ||
0 | <6 | 73% [71–76] | 100% [100–100] | 100% [100–100] | |
6 -<18 | 45% [41–49] | 66% [60–71] | 46% [41–51] | ||
18 -<24 | 35% [28–44] | 51% [40–62] | 44% [32–58] | ||
≥24 | 30% [22–42] | 45% [31–59] | 44% [30–59] | ||
Total | 40% [34–47] | 56% [47–66] | 50% [40–61] | ||
Asia-1 | <2 | <6 | 69% [67–71] | 100% [100–100] | 100% [100–100] |
6 -<18 | 42% [39–46] | 74% [69–79] | 53% [49–58] | ||
18 -<24 | 37% [32–44] | 66% [58–74] | 62% [52–71] | ||
≥24 | 35% [29–43] | 63% [52–73] | 63% [52–73] | ||
Total | 41% [37–47] | 70% [62–76] | 64% [56–71] | ||
0 | <6 | 60% [59–62] | 100% [100–100] | 100% [100–100] | |
6 -<18 | 26% [24–29] | 49% [43–56] | 36% [31–41] | ||
18 -<24 | 22% [17–29] | 41% [30–52] | 38% [25–52] | ||
≥24 | 20% [14–20] | 39% [25–54] | 39% [25–54] | ||
Total | 27% [23–33] | 48% [38–58] | 44% [33–54] | ||
